EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA1c for monitoring and diagnosis of diabetes.

Saved in:
Bibliographic Details
Title: EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA1c for monitoring and diagnosis of diabetes.
Corporate Authors: EurA1c Trial Group
Source: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2026 May 19; Vol. 64 (8), pp. 1886-1900. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42149090
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA<subscript>1c</subscript> for monitoring and diagnosis of diabetes.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22EurA1c+Trial+Group%22">EurA1c Trial Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229806306%22">Clinical chemistry and laboratory medicine</searchLink> [Clin Chem Lab Med] 2026 May 19; Vol. 64 (8), pp. 1886-1900. <i>Date of Electronic Publication: </i>2026 May 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Walter+De+Gruyter%22">Walter De Gruyter </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9806306 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-4331 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214346621%22">14346621 </searchLink><i>NLM ISO Abbreviation: </i>Clin Chem Lab Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42149090
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1515/cclm-2026-0276
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1886
    Titles:
      – TitleFull: EurA1c: a review of 9 years performance of up to 5120 laboratories in 29 country and 26 manufacturer groups according to current and proposed criteria of the IFCC Model for Quality Targets in relation to the use of HbA1c for monitoring and diagnosis of diabetes.
        Type: main
  BibRelationships:
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2026 May 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1437-4331
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical chemistry and laboratory medicine
              Type: main
ResultId 1